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Signiﬁcance Of Reciprocal St Segment Depression In St Elevation Myocardial
Infarction
Mahmoud Knour
Critical Care Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt
BACKGROUND The signiﬁcance of reciprocal ST segment depression (RSTD) during
acute myocardial infarction has been an area of debate, whether it is a sign of mul-
tivessel disease, ischemia at a distance or merely a benign electrical phenomenon.
OBJECTIVE To Study the relationship between the presence of RSTD in ST elevation
myocardial infarction (STEMI) and the extent of coronary artery disease & left ven-
tricular systolic function.
METHODS The current study was conducted as a prospective, randomized, controlled
single center study involving 200 STEMI patients (100 inferior STEMI, 100 anterior
STEMI) admitted to the Critical Care Department, Cairo University in the period be-
tween January 2011 & January 2014. The studied patients were grouped into 2 groups
(A anterior & B inferior STEMI),each group was sub-grouped into 2 subgroups ac-
cording to the presence of RSTD in non-infarcted leads (A1, B1) or absence (A2, B2).
Patients were subjected to echocardiographic assessment of LV systolic function
(LVEF %) & coronary angiography to assess extent & severity of coronary artery dis-
ease using modiﬁed Gensini score (MGS).
RESULTS In both anterior & inferior STEMI, patients with RSTD showed a statistically
signiﬁcant lower mean left ventricular ejection fraction (LVEF) compared to those
without RSTD (373% vs 535% respectively, P< 0.001 in anterior STEMI) & (474%
vs 603%, respectively, P< 0.001 in inferior STEMI).Higher incidence of multivessel
disease was found in subgroups with RSTD (80.5% vs 49.2%, P< 0.001 in anterior
STEMI) & (60% vs 20%, P< 0.001 in inferior STEMI). The mean MGS was signiﬁcantly
higher in subgroups with RSTD compared to those without RSTD (64.212.6 vs
30.26.6, P< 0.001 in anterior STMI)&(36.210.6 vs 20.44.2 ,p<0.001 in inferior
STEMI). In anterior STEMI, patients with RSTD showed a statistically signiﬁcant
higher incidence of signiﬁcant RCA lesions (75.6% vs 42.4%, P< 0.001) & LCX lesions
(48.8% vs 27.1%, P value 0.023). Signiﬁcant LAD lesions were signiﬁcantly higher in
inferior STEMI patients with RSTD (78% vs 24%, P< 0.001).
CONCLUSION Reciprocal ST segment depression in non-infarcted leads in the setting
of acute myocardial infarction (anterior or inferior) was associated with signiﬁcant LV
systolic dysfunction & greater extent of coronary artery disease.
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Telemedicine As A Landmark In The Reduction Of The Door-to-balloon Time In
STEMIs In Distant Areas In A Developing Country
Luis Dallan,1 Vitor Pazolini,1 Camila Matsuda,1 Guilherme Cintra,1 Carlos Opazo,1
Bruno Janella,1 Jamil Cade,1 Roberto Botelho,2 Sameer Mehta,3 Marco A. Perin1
1Hospital Santa Marcelina, Sao Paulo, Brazil; 2ITMS – Global Telemed Systems,
Uberlandia, MG, Brazil; 3University of Miami, Miller School of Medicine; Lumen
Foundation, Miami, FL, FL
BACKGROUND In remote regions of developing countries, far from major hospitals,
there is a serious problem of ineffective treatment of patients with STEMIs, both by
the lack of trained physicians in detecting STEMI as the difﬁculty in transferring the
patient to a hemodynamic laboratory in an effective time. The telemedicine LATIN
program (Latin America Infarct Telemedicine Network) consists on the development
and implementation of a telemedicine protocol in which patients with chest pain in
faraway hospitals are immediately submitted to EKG, which are sent through tele-
medicine to referral centers with cardiologists 24 hours/day responsible for detection
of infarcts. STEMI patients immediately are indicated to primary percutaneous cor-
onary intervention (primary PCI), going straight to the cath lab without having to go
through emergency department of referral hospital.
Hypothesis: The study objective was to evaluate the impact of the LATIN Protocol
on reducing door-to-balloon time in primary PCIs in comparison to the time of the
usual hospital protocol.
METHODS 50 consecutive patients treated by primary PCI STEMIs in periods outside
of normal working hours, ie, were evaluated during the night shift on weekdays and
all day on weekends and holidays. 25 consecutive STEMI patients from the usual
treatment protocol from the institution were included in the period of November 2013
to August 2014, which were compared to 25 LATIN Program patients from September
2014 to November 2014. It was applied chi-square test and student’s t-test, with
statistical power of 90%.
RESULTS The number of STEMIs rose signiﬁcantly after the beginning of LATIN
protocol, since in just 3 months after the institution of this new protocol 25
patients were included, the same equivalent of the last 9 months of those who had
been treated following the usual protocol. The average time from initial EKG at
the original hospital (OH) to ICP at the reference hospital (RH) hospital was 132
(92-300) minutes in patients from LATIN new protocol. The average transfer time
from the OH to the RH was 98,5 (49-260) minutes. The average door-to-balloon
(DTB) time (entry in the RH to ICP) was 32 (26-46) minutes for LATIN protocol
patients, compared with 85 (40-100) minutes of the institution’s standard protocol
DTB time (p <0,05).CONCLUSION LATIN program signiﬁcantly increased the volume of STEMIs treated in
the institution, once it tripled the number of patients treated compared to the usual
protocol. The DTB time was signiﬁcantly reduced after the implementation of tele-
medicine LATIN protocol.
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The Role of Conventional Percutaneous Coronary Intervention, Manual
Thrombectomy and Mechanical Thrombectomy during Primary Percutaneous
Coronary Intervention for ST-segment Elevation Myocardial Infarction:
A Network Meta-Analysis of Randomized Trials
Tilak Pasala,1 Kathir Balakumaran,1 Rama Dilip Gajulapalli,1 Arun Kanmanthareddy,2
Shari Bolen,1 Meera Kondapaneni,1 Ajay J. Kirtane3
1Case Western Reserve University/MetroHealth, Cleveland, OH; 2The Cardiac Center
of Creighton University, Omaha, NE; 3Columbia University Medical Center/
New York-Presbyterian Hospital, New York, NY
BACKGROUND The evidence for the use of conventional percutaneous coronary
intervention (cPCI), manual thrombectomy (MT) and mechanical thrombectomy
(McT) during primary PCI (PPCI) for ST-segment elevation myocardial infarction
(STEMI) is conﬂicting. Moreover, there is a dearth of direct evidence comparing MT
versus McT. A network meta-analysis allows for indirect comparisons in a head-to-
head fashion.
METHODS Electronic search of PubMed, EBSCO, Google Scholar and abstracts from
conferences identiﬁed 41 randomized trials (Fig 1A) that compared the use of at least 2
of the 3 strategies (cPCI, MT, and McT) during PPCI. Mixed treatment analysis was
performed for the earliest available (1-36 months) clinical and procedural endpoints.
RESULTS When compared with cPCI, MT and McT were associated with a lower
incidence of major adverse cardiovascular events (MACE), which is a composite of
death, myocardial infarction (MI) and target vessel revascularization (TVR)(Fig 1B).
The rate of complete ST-segment resolution (> 50-70%) at 60 minutes (STR) and post-
procedural myocardial blush grade  2 (MBG) were higher with MT and McT (Fig 1B).
Additionally, MT was associated with a lower incidence of MI and higher ﬁnal ejection
fraction (EF) compared to cPCI (Figs 1B and 1C). However, MT was no different than
McT for all the endpoints. No statistical inconsistency was noted in the network. MT
was highest in hierarchical ranking order (highest to lowest) by comparative efﬁcacy
for death, MI, stent thrombosis, MBG, EF (up to 3 months) and ﬁnal infarct size (up to
3 months) while McT was highest for MACE, TVR and STR (Fig 1D). cPCI was lowest in
the hierarchical ranking order for all endpoints.
CONCLUSION Reducing the thrombus burden during PPCI for STEMI with either MT
or McT improves clinical outcomes and procedural efﬁcacy compared to cPCI.ANTIPLATELET THERAPY
CRT-126
Clinical Impact Of Platelet Reactivity In Korean Patients With Coronary Artery
Disease
Sang Yeub Lee, Ju-Hee Lee, Sang Min Kim, Jang-Whan Bae, Kyung-Kuk Hwang,
Dong-Woon Kim, Myeong-Chan Cho
Chungbuk Regional cardiovascular center, Cheongju-Si, Korea, Republic of
BACKGROUND Platelets are closely associated with vascular occlusive event.
METHODS We evaluated platelet reactivity measured by the VerifyNow P2Y12 assay
and clinical outcomes in patients with coronary artery disease treated with clopi-
dogrel and percutaneous coronary intervention of real world practice. We recruited
S16 J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 8 , N O . 2 , S U P P L S , 2 0 1 5
C
O
R
O
N
A
R
Yclopidogrel-treated patients undergoing emergent or elective PCI for stable angina or
acute coronary syndrome (non-ST-elevation and ST-elevation myocardial infarction,
unstable angina). The main outcome measures were cardiovascular (CV) death, def-
inite/probable stent thrombosis (ST), nonfatal myocardial infarction (MI), coronary
revascularization (PCI or CABG) and a composite end point of ischemic events. High
platelet reactivity (HPR) was deﬁned as PRU (P2Y12 Reaction Unit) value  240 or 252.
RESULTS In total, 1038 consecutive patients were enrolled (Male 749, 72.7%). Pa-
tients with HPR were 487 (46.9%). VerifyNow P2Y12 cartridge was used in 1038 pa-
tients. All patients received optimal clopidogrel pretreatment and maintenance
therapy. At a 12-month follow-up, we found 85 ischemic events (18 CV deaths [1.7%],
7 nonfatal MIs [0.7%]), 5 stent thrombosis (0.5%) and 47 target-vessel re-
vascularizations (4.5%). The CV rate of patients with HPR (PRU > 240) was signiﬁ-
cantly higher rate (2.7% vs 1.0% (p ¼ 0.030)) than the patients with normal value. The
composite end point event rate of patients with HPR (PRU > 240) was also signiﬁ-
cantly higher rate (8.07% vs 4.5% (p ¼ 0.020)) than the patients with normal value. In
survival analysis, there was no signiﬁcant difference between patient with HPR (PRU
> 240) and normal reactivity. But between patient with HPR (PRU > 252, cutoff value
of CILON-T trial) and normal reactivity, the survival rate free from the CV death was
signiﬁcantly lower in patients with high on-treatment platelet reactivity(p ¼ 0.037,
Log Rank test).
CONCLUSION HPR tested by VerifyNow predict coronary adverse event in patients
after PCI. In Korean, the rate of HPR was higher than western people and we seem to
have to raise the optimal cutoff value of PRU to predict future coronary event in
Korean.
CRT-127
Assessment Of Impact Of Chronic Kidney Disease On Platelet Inhibition Among
Post Percutaneous Intervention Patients On Antiplatelet Therapy
Maddury Jyotsna, Ashok Kumar Arigondam, Siva Krishna Venkata
Nizam’s institute of medical sciences, Secunderabad, India
BACKGROUND CKD may inﬂuence the response to antiplatelet therapy. We, there-
fore, sought to investigate its effect on platelet inhibition according to its stages.
METHODS We assessed platelet inhibition (PI) among those patients on dual anti-
platelet regimen (75 mg of Aspirin and 75 mg of clopidogrel) in various stages of CKD
in 922 patients after PCI with stent implantation. Platelet inhibition was tested with
platelet aggregometry. Effective PI is deﬁned as > 50% platelet inhibition. CKD was
deﬁned as a estimated glomerular ﬁltration rate (eGFR) <60 mL/min/1.73 m2 . eGFR
was estimated by MDRD formula. We analyzed PI levels with eGFR values using
Pearson correlation test.
RESULTS Total no of cases are 922. Male:female::3.4:1. 606 (66%) were hyperten-
sives, 417 (45%) were diabetics and 224 (24%) were smokers. 548 (59%) pts were
presented with ACS and multi vessel angioplasty was done in 214 (23%) patients.
Total no of lesions treated were 1225 in 922 pts . Prevalence of patients according
to stages of CKD were - Stage 1 - 209(23%); Stage 2 - 415 45(%);Stage 3a - 158 (17%);
Stage 3b - 104 (11%); Stage 4 - 15 (1.6%); Stage 5 - 19(2%) pts. There was no correlation
between estimated GFR and percentage of inhibition of platelets in all pts (Pearson
correlation ¼ -0.021; p Value ¼ 0.7) and in different stages CKD pts (Stage 1 -
Pearson correlation ¼ -0.039, p value ¼ 0.8, Stage 2 - correlation ¼ -0.008, p ¼ 0.9,
Stage 3a correlation ¼ -0.002, p ¼ 0.98, Stage 3b correlation ¼ 0.052, p ¼ 0.8, Stage 4
correlation ¼ 0.9, p ¼ 0.1 and Stage 5 correlation ¼ -0.6, p ¼ 0.3) .
CONCLUSION Presence of CKD (including the all stages) does not inﬂuence the
effectiveness of platelet inhibition with antiplatelet therapy in pts undergoing PCI for
obstructive CAD.ATHERECTOMY DEVICES
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Safety of Rotational Atherectomy in High Risk PCI with Hemodynamic Support
Soha Ahmad, Han Tun, Michael Gaglia, Anilkumar Mehra, Ray V. Matthews,
David M. Shavelle, Leonardo Clavijo
University of Southern California, Los Angeles, CA
BACKGROUND Rotational atherectomy (RA) can aid in high risk Percutaneous Coro-
nary Intervention (PCI) with hemodynamic support. There is concern that use of RA
could result in increased procedural complications. We report our institution’s
experience with RA in high risk PCI with hemodynamic support.
METHODS 398 patients underwent high risk PCI with intraaortic balloon pump (IABP)
(n¼327), Impella (n¼57), or Tandem Heart (n¼14) between 2008 and July 2014.
Patients with ST elevated myocardial infarction were excluded (n¼129). Patients who
underwent RA (n¼34) were compared to those who did not (n¼235). Among the 34
patients who underwent RA, Impella use (n¼10) versus IABP use (n¼23) was
compared.
RESULTS Patients in the RA arm were older (71.9114.47 vs. 64.7712.63, p¼0.003)
and less likely in cardiogenic shock (6% vs. 23%, p¼0.02). There was no difference inthe number of diseased vessels (RA¼ 2.860.88 vs. no RA ¼2.680.99, p¼NS),
location of vessels, or number of total occlusions (RA ¼ 32% vs. no RA ¼32%, p¼NS).
PCI without stent deployment was less common in the RA arm (15% vs. 37%, p¼0.01).
There was no difference in stent diameter or length. There was a trend toward more
Impella use, but this was not statistically different (RA ¼ 29% vs. no RA ¼18%, p¼NS).
There was no difference in morbidity, hospital mortality, recurrent MI, or repeat
revascularization. Within the rotational atherectomy group, there was no difference
in outcome between IABP or Impella 2.5.
CONCLUSION In our center’s experience, use of rotational atherectomy in high risk
PCI with hemodynamic support is feasible and not associated with increased
morbidity or mortality.CRT-129
One-year Safety Outcomes In Diabetic Patients Treated With Orbital
Atherectomy For De Novo, Severely Calciﬁed Coronary Lesions: A Sub-analysis
Of The ORBIT II Trial
Jeffrey W. Chambers,1 Arthur C. Lee2
1Metropolitan Heart and Vascular Institute, Minneapolis, MN; 2The Cardiac and
Vascular Institute, Gainesville, FL
BACKGROUND Patients with diabetes mellitus (DM) are at increased risk for severe
coronary artery calciﬁcation. Severely calciﬁed lesions make successful balloon an-
gioplasty and stent delivery more difﬁcult during percutaneous coronary interven-
tion (PCI) and treatment may lead to serious procedural complications. Compared to
non-diabetics, diabetics have increased incidence of major adverse cardiac events
(MACE) after PCI. In this analysis, we compared 1-year safety outcomes in ORBIT II
patients with or without DM treated with the Diamondback 360 Coronary Orbital
Atherectomy System (OAS) (Cardiovascular Systems, Inc., St. Paul, MN).
METHODS ORBIT II, a prospective, multi-center trial conducted in the US, was
designed to evaluate the safety and efﬁcacy of the Diamondback 360 Coronary OAS to
prepare de novo, severely calciﬁed coronary lesions for stent deployment. Freedom
from 1-year MACE (deﬁned as cardiac death, myocardial infarction (MI, CK-MB>3X
ULN), and target vessel revascularization (TVR)) was compared in patients with his-
tory of DM (DM group, N¼160) versus patients without history of DM (no-DM group,
N¼283).
RESULTS Patients in the DM group were younger (70.3  0.7 vs 72.0  0.6, p¼0.02),
had higher BMI (31.0  0.5 vs 28.5  0.3, p<0.0001), higher prevalence of hyperten-
sion (96.3% vs 89.0%, p¼0.01), and higher rate of previous coronary artery bypass
graft (20.0% vs 11.7%, p¼0.02). As estimated by Kaplan-Meier, at one one-year both
DM and non-DM patients had similar high freedom from MACE (83.5% vs 83.6%,
